From Name:
From Email:
To Name:
To Email:

Optional Message:

Oklahoma researchers battle resistant bacteria

from The Oklahoman

With E. coli diagnoses showing up across the United States, and even overseas, an Oklahoma research company's plans for an immune resistant antibiotic couldn't come at a better time. Biolytx Pharmaceuticals Corp. — an early-stage company based on the intellectual property of University of Oklahoma Health Sciences Center — is in the preclinical stages of producing an antibiotic that doctors will use to kill strains of increasingly resistant bacteria, said H. Anne Pereira, associate dean for research for the University of Oklahoma College of Pharmacy. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063